Affiliation:
1. Department of Psychology and Neuroscience Baylor University Waco Texas USA
2. Institute of Biomedical Studies Baylor University Waco Texas USA
3. Department of Biology Baylor University Waco Texas USA
Abstract
AbstractObjectivesFragile X syndrome is the main monogenetic cause of intellectual disability and autism. Alterations in the immune system are commonly found in these developmental disorders. We and others have demonstrated that Fmr1 mutant mice present an altered response to immune stimuli. However, whether this altered immune response can influence the Fmr1 mutant behavioral outcomes in response to inflammation has not been fully investigated.Materials and methodsIn the current study, we examine the behavioral sickness response of male wildtype and knockout mice to the innate immune stimulus lipopolysaccharide (LPS) (0.1 mg/kg) to determine if Fmr1 mutants have altered sickness behavior. We used an enzyme‐linked immunosorbent assay (ELISA) to measure changes in the cytokine interleukin‐6 (IL‐6) to determine that inflammation was induced in the mice. Sickness behavior was assessed in a wheel‐running paradigm, and a tail suspension test was used to assess the depressive‐like phenotype that follows sickness behavior in response to LPS.ResultsThe ELISA using blood serum confirmed a significant increase in IL‐6 in mice that were treated with LPS. Treated Fmr1 mutants exhibited decreased distance traveled in the wheel running after LPS administration, similar to treated controls. Another cohort of animals treated with LPS were tested in the tail suspension test and exhibited no alterations in immobility time in response to LPS.ConclusionTogether, our data suggest that Fmr1 mutant mice do not have altered sickness behavior in response to a low dose of LPS.
Funder
National Institute of Neurological Disorders and Stroke
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献